Boston Scientific Corporation (NYSE:BSX) dropped -0.51% and closed the trade at $ 23.50. The company recorded a trading capacity of 13.25 million shares above its three months average daily volume of 9.07 million shares. During the last trade, shares reached to high price of $23.68 and touched the low price of $23.38. The stock’s 50-day moving average is noted at $24.02 and its 200-day moving average is stands at $21.85.
Additionally, the company has EPS of -0.26. The company has market capitalization of $31.98B.
Currently Boston Scientific Corporation (BSX) captured an average recommendation of “ Buy ” from analysts, according to FactSet data. The stock has been suggested as “Buy” from “22″ Analysts”. “0” rated “Sell” for the company. “7” said the company as a “Hold”. Overweight rating was given by “0” and Underweight rating was given by “0”.
Analysts are expecting that the company to achieve $26.92 Price Target in next 52-weeks, average price is come up through the consensus of analysts. High potential price target is set at $31.00 however minimum price target advised by analysts is $19.00. The Median price target for the stock is measured at $28.00.
Presently, Analysts decided consensus EPS estimate of $0.27 for present quarter and one month ago projected EPS estimate was at $0.27. If we take a look at back 3 month ago, consensus EPS estimate was $0.27.
A current consensus EPS estimate for next quarter is at $0.29 and 3 month ago EPS forecast was $0.28. Have a look at back 1 month ago, consensus EPS forecast was seen at $0.29.
For current fiscal year, most recent EPS estimate is set at $1.10 based on Analyst consensus and three month ago consensus EPS opinions was at $1.09. During period one month ago, consensus EPS forecast was decided at $1.10.
A current consensus EPS projection for next fiscal year is observed at $1.26 and one month ago consensus EPS forecast was at $1.26. Take a look at back three month ago, consensus EPS estimate opinions was decided at $1.24 by analysts.
One Month ago, the stock has gained consensus mean rating of Overweight based on the analysis of brokerage analyst firms polled. 21 presented the recommendations about the stock as a “Buy” signal and “Overweight” signal was reported by 0. 8 advised the “Hold” rating about this stock. 0 revealed “Sell” signal and “Underweight” rating was declared by 0.
Three Months Ago, Analysts recommended an average brokerage rating of Overweight derived from brokerage firms, according to FactSet. 22 said a “Buy Rating” and 0 announced “Overweight Rating”. 8 advised “Hold Rating” regarding the stock. 0 announced “Sell Rating” and 0 disclosed “Underweight Rating”.